Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy

Neurology

Volumn 66, Issue 3, 2006, Pages 442-443

  Linnebank, M ^a   Kemp, S ^b   Wanders, R J A ^b   Kleijer, W J ^c   Van Der Sterre, M L T ^c   Gartner J ^d   Fliessbach, K ^a   Semmler, A ^a   Sokolowski, P ^e   Kohler W ^e   Schlegel, U ^a,f   Schmidt, S ^a   Klockgether, T ^a   Wullner U ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e Sachsisches Krankenhaus Hubertusburg   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE;

ADRENOLEUKODYSTROPHY; AMINO ACID METABOLISM; ARTICLE; DEMYELINATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHIONINE METABOLISM; PHENOTYPE; PRIORITY JOURNAL; X CHROMOSOME LINKED DISORDER; ADOLESCENT; CHILD; CLASSIFICATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; METABOLISM;

ADOLESCENT; ADRENOLEUKODYSTROPHY; CHILD; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHIONINE; PHENOTYPE; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 33646185826     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000196491.42058.6f     Document Type: Article

References (10)

1. Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997;120:1485-1508.
2. Moser HW, Moser AB, Smith KD, et al. Adrenoleukodystrophy: phenotypic variability and implications for therapy. J Inherit Metab Dis 1992;15:645-664.
3. van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 2001;49:186-194.
4. Kumar AJ, Köhler W, Kruse B, et al. MR findings in adult-onset adrenoleukodystrophy. AJNR Am J Neuroradiol 1995;16:1227-1237.
5. Dodd A, Rowland SA, Hawkes SLJ, Kennedy MA, Love DR. Mutations in the adrenoleukodystrophy gene. Hum Mutat 1997;9:500-511.
6. Gärtner J, Braun A, Holzinger A, Roerig P, Lenard HG, Roscher AA. Clinical and genetic aspects of X-linked adrenoleukodystrophy. Neuropediatrics 1998;29:3-13.
7. Kok F, Neumann S, Sarde CO, et al. Mutational analysis of patients with X-linked adrenoleukodystrophy. Hum Mutat 1995;6:104-115.
8. Linnebank M, Pels H, Kleczar N, et al. MTX-induced white matter changes are associated with polymorphisms of methionine-metabolism. Neurology 2005;64:912-913.
9. Mudd SH, Levy HL, Kraus JP. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, et al., eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:2007-2056.
10. Surtees R, Leonard J, Austin S. Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 1991;338:1550-1554.